DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Haioun C, Lepage E, Gisselbrecht C. et al.
Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin’s lymphoma: final analysis of the prospective LNH87 - 2 protocol - a groupe d’Etude des lymphomes de l’Adulte study.
J Clin Oncol 2000; 18: 3025-3030
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.